Keyphrases
Acute Kidney Injury
27%
Antihyperglycemic
20%
Asthma
72%
Beta-blockers
23%
Cardiovascular Disease
36%
Cardiovascular Risk Prediction
20%
Chronic Obstructive Pulmonary Disease
32%
Chronic Obstructive Pulmonary Disease Patient
20%
Clinical Practice Research Datalink
21%
Comorbidity
100%
Competing Risks
25%
Confidence Interval
41%
COVID-19
99%
COVID-19 Pandemic
24%
COVID-19 Patients
21%
Electronic Health Records
29%
Europe
19%
External Validation
29%
Fluoroquinolones
27%
France
23%
Germany
33%
Hazard Ratio
27%
Hospitalization
29%
Incidence Rate
24%
Influenza
20%
International Networks
23%
Interrupted Time Series
20%
Interrupted Time Series Regression
28%
Label Change
20%
Meta-analysis
36%
Methodological Considerations
20%
Multinational Network
27%
Nested Case-control Study
31%
Netherlands
20%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
22%
Older People
31%
People with Dementia
20%
Performance Prediction
20%
Population Cohort Study
27%
Population-based
69%
Primary Care
62%
Respiratory Effects
20%
Retrospective Cohort Study
21%
Risk Prediction Tool
22%
Scotland
56%
Sectional Analysis
27%
South Korea
28%
Spain
37%
Time Series Regression Analysis
23%
Type 2 Diabetes Mellitus (T2DM)
30%
Medicine and Dentistry
Acute Kidney Injury
22%
Adverse Event
11%
Antidepressant
13%
Apoplexy
16%
Asthma
10%
Cardiovascular Disease
43%
Cardiovascular Risk
22%
Cardiovascular System
28%
Chronic Obstructive Pulmonary Disease
16%
Clinical Guideline
12%
Clinical Population
20%
Clinical Trial
11%
Cohort Analysis
73%
Cohort Effect
35%
Comorbidity
60%
COVID-19
92%
Cross Sectional Study
33%
Decision Making
10%
Disease
26%
Diseases
11%
Drug Therapy
22%
Electronic Health Record
27%
Fragility Fracture
13%
General Medicine
11%
Glucagon-Like Peptide-1 Agonist
10%
Glycon
12%
Hazard Ratio
16%
Hip Fracture
13%
Human Immunodeficiency Virus
13%
Malignant Neoplasm
11%
Maturity Onset Diabetes of the Young
29%
Medicine
38%
Meta-Analysis
12%
Multiple Chronic Conditions
25%
Observational Study
21%
Odds Ratio
22%
Opiate
22%
Pancreas Cancer
13%
Pharmacovigilance
16%
Population
13%
Prevalence
20%
Primary Health Care
58%
Randomized Controlled Trial
30%
Sodium Glucose Cotransporter 2 Inhibitor
10%
Sulfonylurea
13%
Symptomatic Treatment
13%
Systematic Review
27%
Thrombocytopenia
14%
Thrombosis
15%
Time Series Analysis
26%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
25%
Adverse Event
20%
Analgesic Agent
9%
Antibiotics
15%
Antidepressant
20%
Antipsychotic
20%
Asthma
58%
Azithromycin
11%
Beta Adrenergic Receptor Blocking Agent
20%
Bisphosphonic Acid Derivative
12%
Cardiovascular Disease
37%
Case-Control Study
29%
Cerebrovascular Accident
12%
Chronic Obstructive Lung Disease
25%
Cohort Study
94%
Comorbidity
33%
Coronavirinae
37%
COVID-19 Vaccine
10%
Cross-Sectional Study
15%
Diclofenac
13%
Dipeptidyl Carboxypeptidase Inhibitor
13%
Disease
60%
Diuretic Agent
10%
Drug Development
13%
Drug Safety
9%
Drug Utilization
13%
Epidemiology
20%
Fragility Fracture
20%
Hip Fracture
13%
Hydroxychloroquine
14%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
Infection
10%
Kidney Disease
9%
Monotherapy
12%
Multiple Chronic Conditions
17%
Non Insulin Dependent Diabetes Mellitus
25%
Observational Study
28%
Opiate
16%
Pandemic
11%
Pharmacovigilance
27%
Prevalence
30%
Quinolone Derivative
29%
Randomized Controlled Trial
28%
Risk Communication
13%
SARS Coronavirus
12%
Sulfonylurea
12%
Tendon Rupture
13%
Thrombocytopenia
14%
Thrombosis
18%
Typical Antipsychotic
11%